| NM | NM + AEHE | DM | DM + LAEHE | DM + HAEHE | DM + Gli |
---|
TG (mmol/L) | 1.39 ± 0.31 | 1.41 ± 0.39 | 2.51 ± 0.36a
| 2.01 ± 0.41b
| 1.46 ± 0.37c
| 1.42 ± 0.31c
|
TC (mmol/L) | 1.67 ± 0.29 | 1.72 ± 0.35 | 2.69 ± 0.32a
| 2.13 ± 0.41c
| 1.71 ± 0.31c
| 1.72 ± 0.34c
|
HDL-C (mmol/L) | 1.24 ± 0.25 | 1.29 ± 0.29 | 0.89 ± 0.29a
| 1.01 ± 0.20 | 1.19 ± 0.23b
| 1.22 ± 0.26b
|
LDL-C (mmol/L) | 0.54 ± 0.07 | 0.61 ± 0.09 | 0.81 ± 0.12a
| 0.77 ± 0.09 | 0.65 ± 0.06c
| 0.59 ± 0.08c
|
- Values are expressed as mean ± SD in each group. NM group: normal control rats treated with vehicle alone; NM + AEHE group: normal control rats treated with AEHE (100 mg/kg b.w.); DM group: diabetic control rats treated with vehicle alone; DM + LAEHE group: diabetic rats were given AEHE (100 mg/kg b.w.); DM + HAEHE group: diabetic rats were given AEHE (200 mg/kg b.w.); DM + Gli group: diabetic rats were given glibenclamide (30 mg/kg b.w.). aindicates statistical significance of P < 0.05 compared to the NM group; bindicates statistical significance of P < 0.05 compared to the DM group. cindicates statistical significance of P < 0.01 compared to the DM group.